Position in IDYA
as of Dec 31, 2025
· filed Feb 9, 2026
Position Value
$1,340,175
+$223,804 QoQ
Shares Held
38,767
-5.5% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025AlphaQuest LLC holds $49,086,740 across 144 Biotechnology names. IDYA ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
130,106 | $3,036,674 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
142,501 | $2,029,214 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
20,664 | $1,645,887 | |
| 4 | CGON |
CG Oncology, Inc.
|
38,894 | $1,614,878 | |
| 5 | TARS |
Tarsus Pharmaceuticals, Inc.
|
19,193 | $1,571,522 | |
| 6 | OMER |
Omeros Corp
|
82,597 | $1,419,016 | |
| 7 | IDYA |
IDEAYA Biosciences, Inc.
This page
|
38,767 | $1,340,175 | |
| 8 | IMNM |
Immunome Inc.
|
48,968 | $1,051,832 |
All Filings in IDYA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1,340,175 | 38,767 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,116,371 | 41,028 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $224,241 | 10,668 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $449,319 | 27,431 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $196,887 | 7,661 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,079,084 | 34,062 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $41,359 | 1,178 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||